PET Imaging of Adenosine Receptors in Diseases

Curr Top Med Chem. 2019;19(16):1445-1463. doi: 10.2174/1568026619666190708163407.

Abstract

Adenosine receptors (ARs) are a class of purinergic G-protein-coupled receptors (GPCRs). Extracellular adenosine is a pivotal regulation molecule that adjusts physiological function through the interaction with four ARs: A1R, A2AR, A2BR, and A3R. Alterations of ARs function and expression have been studied in neurological diseases (epilepsy, Alzheimer's disease, and Parkinson's disease), cardiovascular diseases, cancer, and inflammation and autoimmune diseases. A series of Positron Emission Tomography (PET) probes for imaging ARs have been developed. The PET imaging probes have provided valuable information for diagnosis and therapy of diseases related to alterations of ARs expression. This review presents a concise overview of various ARs-targeted radioligands for PET imaging in diseases. The most recent advances in PET imaging studies by using ARs-targeted probes are briefly summarized.

Keywords: ATP; Adenosine receptors (ARs); Diseases; G-protein-coupled receptors (GPCRs); Molecular imaging probe; Positron emission tomography (PET)..

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / diagnostic imaging
  • Autoimmune Diseases / metabolism*
  • Cardiovascular Diseases / diagnostic imaging
  • Cardiovascular Diseases / metabolism*
  • Humans
  • Inflammation / diagnostic imaging
  • Inflammation / metabolism*
  • Molecular Probes / chemistry
  • Nervous System Diseases / diagnostic imaging
  • Nervous System Diseases / metabolism*
  • Positron-Emission Tomography*
  • Receptors, Purinergic P1 / analysis*

Substances

  • Molecular Probes
  • Receptors, Purinergic P1